Rev/RRE-Independent Mason–Pfizer Monkey Virus Constitutive Transport Element-Dependent Propagation of SIVmac239 Vectors Using a Single Round of Replication Assay  by Rizvi, Tahir A. et al.
VIROLOGY 222, 457–463 (1996)
ARTICLE NO. 0444
SHORT COMMUNICATION
Rev/RRE-Independent Mason–Pfizer Monkey Virus Constitutive Transport Element-Dependent
Propagation of SIVmac239 Vectors Using a Single Round of Replication Assay
TAHIR A. RIZVI,*,†,1 RUSSELL D. SCHMIDT,* KATHY A. LEW,* and MICHALE E. KEELING*
*Department of Veterinary Sciences, The University of Texas M. D. Anderson Cancer Center, Bastrop, Texas 78602; and †Department of
Carcinogenesis, Science Park—Research Division, The University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957
Received March 27, 1996; accepted June 12, 1996
In a step toward creating live-attenuated or DNA subunit vaccines for AIDS, the replication of simian immunodeficiency
virus (SIV) was studied independently of the Rev and RRE (Rev-responsive element) regulatory system, over a single round.
To accomplish this, the env gene of an SIV vector was made defective by the insertion of a SV40 promoter/enhancer
hygromycin B phosphotransferase gene cassette. Using this vector as the backbone, molecular clones of SIV were generated
that contained a mutated Rev, Rev(0), a deleted RRE, RRE(0), or both, Rev(0)RRE(0). It has been shown recently that human
immunodeficiency virus type 1 (HIV-1) Rev and RRE functions can be replaced in vitro by a cis-acting sequence, constitutive
transport element (CTE), from simian type D retroviruses. To determine whether such a cis-acting element from Mason–
Pfizer monkey virus (MPMV) would substitute for SIV Rev and RRE functions, the MPMV CTE was inserted either into the
Nef ORF or at the junction of vpx and vpr of our Rev(0), RRE(0), and Rev(0)RRE(0) SIV molecular clones. Cell-free viral
stocks harvested from Cos cells following transfections of these molecular clones revealed that these stocks were infectious
over a single round of replication; however, their replication was attenuated 16-fold compared to that of wild-type virus. In
addition, our experiments revealed that CTE functions in a position-dependent manner such that its insertion at the junction
of vpx and vpr attenuated SIV replication 8- to 12-fold compared to the attenuation observed when it was inserted in the
nef region. Our results demonstrate that MPMV CTE is capable of substituting for SIV Rev and RRE functions, resulting in
an attenuated ability to produce infectious virus. q 1996 Academic Press, Inc.
Transport of messages from the nucleus to the cyto- Recently, two independent studies have shown that
cis-acting elements present in the 3* region of type Dplasm is an essential step in the retroviral life cycle. If
retroviruses, Mason–Pfizer monkey virus (MPMV) andnot accomplished properly, replication-defective viruses
simian retrovirus type 1 (SRV-1), can substitute for thecan result since nuclear-sequestered messages cannot
HIV-1 Rev/RRE regulatory system (3, 32). Once these con-be translated (for review, see 5). Human immunodefi-
stitutive transport elements (CTEs) are inserted beforeciency virus type 1 (HIV-1) and simian immunodeficiency
the polyadenylation sequences of either HIV-1 gag/polvirus (SIV) have developed a highly efficient mechanism,
or env expression vectors (3) or in the nef gene of athe Rev/RRE (Rev responsive element) system, to regu-
Rev(0) full-length HIV-1 proviral DNA (3, 32), the expres-late the expression of incompletely spliced and un-
sion of the unspliced and singly spliced genes and evenspliced mRNAs. In the absence of the Rev/RRE regulatory
the replication of the virus become independent of thesystem, these messages remain trapped in the nucleus
Rev/RRE regulatory system, though in an attenuateduntil they are spliced, exported out of the nucleus, or
manner. Since no other viral protein is required for MPMVdegraded (9, 10, 20, 21). Binding of Rev to its cis-acting
CTE function, Bray et al. (3) suggested that MPMV CTEresponsive element, RRE, found in these messages
may interact with cellular factors to allow nucleocytoplas-allows the expression of such messages (1, 6, 10, 16,
mic transport of viral mRNAs. Similar cis-acting elements29; for more references, see 5). Rev may accomplish this
have been discovered in hepatitis B (17, 18) and rousby binding to cellular cofactors involved in the export of
sarcoma viruses (23).messages from the nucleus to the cytoplasm (2, 11, 13,
The ability of CTE to obviate the need for the Rev/RRE30), resulting in enough structural gene products to allow
regulatory system in the case of HIV-1 prompted us toa complete replication cycle to take place.
test this phenomenon in the case of SIV. We were inter-
ested in generating infectious molecular clones of SIV1 To whom correspondence and reprint requests should be ad-
that could be used as pathogenically attenuated yet repli-dressed at Department of Veterinary Sciences, The University of Texas
cation-competent vaccines. The studies conducted ear-M. D. Anderson Cancer Center, Route 2, Box 151-B1, Bastrop, TX 78602.
Fax: (512) 332-5208. E-mail: tarfm@aol.com. lier for HIV-1 had weaknesses that resulted in many
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unanswered questions (3, 32). Foremost among these, since RRE is known to contain sequences inhibitory to
the transport of unspliced messages (4, 22). Analysesboth groups had used viral replication assays based on
multiple rounds of replication; the use of such assays, such as these could not be accomplished in earlier pub-
lished reports due to the overlap of RRE and the Env ORFespecially for long-term virus propagation, can lead to
reversion of introduced mutations, generation of second- (3, 32). To avoid any possible homologous recombination
between the RRE-containing sequences carried by thesite revertants, and potential loss of unstable genetic
elements that may lead to ambiguity in the interpretation homologous env expression plasmid and the sequences
in the vector, a heterologous murine amphotropic envof results. In addition, the cumulative effects of several
rounds of replication have the potential of masking subtle (pSV-A-MLV-env) was used to pseudotype SIV particles.
Pseudotyping by the murine amphotropic env has beendifferences that may exist, while magnifying others that
may be present at low levels. For example, reversion of demonstrated to yield higher titers of virus than trans
complementation with the homologous env in HIV-1 (7,even one molecule of functional Rev could account for
the results obtained by Bray et al. (3) since sequences 14, 24). Finally, by deleting RRE completely, this assay
also allowed us to use Rev in trans to study any possibleencoding RRE were still present in their molecular
clones. Zolotukhin et al. (32) had introduced double muta- Rev/CTE interactions that may exist.
SIVmac239 has been cloned in two halves with env,tions in Rev and multiple mutations in RRE to circumvent
this problem. However, even partial reversion of muta- rev, RRE, and nef residing in the 3* half (p239SpE3*) of
the virus (19). To generate the full-length viral genome,tions in Rev or compensatory second-site mutations in
RRE could have led to virus replication. The fact that the 5* half (p239SpSp5*) was ligated in vitro with the 3*
half, following cleavage by BstBI (Fig. 1) as describedZolotukhin et al. (32) had found 11 point mutations in RRE,
even by Day 14, further substantiates such concerns. previously (25, 26). Transfection of Cos cells with the
ligated vector DNA along with a plasmid expressing mu-In addition, there were discrepancies between the two
studies; for example, Bray et al. (3) reported an attenua- rine amphotropic env (pSV-A-MLV-env) resulted in the
production of infectious SIV particles from the Cos cellstion of viral replication of two orders of magnitude,
whereas Zolotukhin et al. (32) observed an attenuation via genetic complementation. Stocks of these viruses
were used to infect HeLaT4 cells and the infected cellsof 5- to 10-fold. Thus, we decided to systematically and
quantitatively measure the effect of CTE on SIV replica- were selected in media containing hygromycin B. Only
cells with successful integration of vector DNA and ex-tion and reevaluate its role in HIV-1 replication in the
absence of the Rev/RRE regulatory system using a single pressing the hygr gene gave rise to hygromycin resistant
(Hygr) colonies. The number of Hygr colonies that sur-round of replication assay.
To study the role of CTE in the Rev/RRE-independent vived directly reflected the ability of a particular pseu-
dotyped particle to infect and integrate in the cellularreplication of SIV, we established a trans complementa-
tion assay based on assays developed earlier to study genome. Thus, by using a single round of replication
assay, we were able to evaluate the ability of MPMV CTEpropagation and pseudotyping of replication-defective
SIV (25–27) and HIV-1 vectors (7, 14, 24) without the to substitute for the Rev/RRE regulatory system in the
replication of SIV in a controlled and quantitative manner.generation of replication-competent viruses in a single
round of replication. This assay used a previously de- Table 1 reveals the results of several trans complementa-
tion experiments performed using the Rev(0), RRE(0), andscribed SIV vector, pTR140, containing the SV40 pro-
moter/enhancer hygromycin B phosphotransferase (hygr) Rev(0)RRE(0) SIV molecular clones with or without the
insertion of MPMV CTE. The control vector, pTR140, con-gene ‘‘cassette’’ (SV-Hygr cassette) inserted in the env
region (25, 26). Propagation of this vector was dependent taining all intact genes except env, was able to replicate
well, giving rise to over 3000 colony-forming units (CFU)/upon complementation in trans by an env-expression
plasmid. A series of molecular clones was created by ml of viral stock. However, when RRE was deleted, as for
pTR216, or when Rev was mutated, as for pTR238, or whenmodifying pTR140 defective in Rev, in RRE, or in both.
MPMV CTE was inserted at the BglII site in the nef gene both Rev and RRE were disrupted, as for pTR244, no colo-
nies were observed. This was expected since mutations inof these vectors. In order to mutate the SIV Rev ORF, a
premature stop codon was introduced at amino acid 12 either Rev or RRE disrupt the Rev/RRE regulatory system
essential for the replication of the virus (9, 10, 20, 21). How-in the second exon in Rev. This mutation in Rev changed
a lysine to isoleucine in exon 2 in Tat, a modification ever, when the Rev(0) vector pTR238 was complemented
with Rev in trans, virus replication was restored, though notthat does not affect Tat function (Scott Wong, personal
communication). To disrupt the RRE, a deletion mutation to the wild-type levels (1050 vs 3168 CFU/ml). To make
sure that the Rev mutation did not affect Tat function, Tatwas introduced that completely eliminated sequences
encompassing RRE. We were able to delete RRE without was provided in trans; however, no increase in viral titers
was observed (data not shown). These results could haveconsideration for the overlapping env ORF since env was
provided in trans by a separate expression plasmid. been due to several factors: first, several independent
DNAs were used in the transfection procedure, causingStudy of CTE in the complete absence of RRE is important
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FIG. 1. Schematic representation of the SIVmac239 genome with open reading frames (ORFs) and SIV vectors with the insertion of MPMV CTE
in the nef region. Details of the origin and construction of these plasmids can be obtained from the authors upon request. The broken lines represent
the site of in vitro ligation of the SIV vectors with p239SpSp5* at the BstBI site. RRE, Rev-responsive element; SV, SV 40 early promoter; hyg r,
hygromycin B phosphotransferase gene.
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TABLE 1
Effect of MPMV CTE on the Propagation of Rev(0), RRE(0), and Rev(0)RRE(0) SIV Vectorsa
Presence or absence Titer (CFU/ml { SD)b
of MPMV CTE in HIV-1 Rev
Rev/RRE
Vector phenotype nef vpx/vpr (/) (0)
pTR140 Rev(/)RRE(/) CTE(0) — NDc 3168 { 32
pTR216 Rev(/)RRE(0) CTE(0) — ND 0
pTR229 Rev(/)RRE(0) CTE(/) — ND 197 { 3
pTR230 Rev(/)RRE(0) CTE(/)d — ND 0
pTR238 Rev(0)RRE(/) CTE(0) — 1050 { 50 0
pTR245 Rev(0)RRE(/) CTE(/) — 869 { 10 193 { 3
pTR244 Rev(0)RRE(0) CTE(0) — ND 0
pTR247 Rev(0)RRE(0) CTE(/) — ND 199 { 1
pTR304 Rev(/)RRE(/) — CTE(/) ND 3093 { 11
pTR255 Rev(/)RRE(0) — CTE(/) ND 22 { 3
pTR258 Rev(0)RRE(0) — CTE(/) ND 16 { 2
a All vectors were in vitro ligated individually with p239SpSp5* following BstBI digestion as described earlier (25, 26). In vitro-ligated samples
were cotransfected with pSV-A-MLV-env.
b All data represent experiments performed in parallel and are based on a minimum of three independent experiments with two duplicate samples
per experiment. No Hygr colonies were observed for mock, pSV-A-MLV-env alone, or any of the vectors when transfected without pSV-A-MLV-env.
c ND, Not done.
d MPMV CTE was inserted in the antisense orientation.
possible competition among the DNAs for their expression. The results presented above also revealed that no
positive Rev-CTE interactions existed. We could studySecond, Rev was provided in trans rather than cis, and as
a result it may not have functioned optimally. Finally, HIV-1 the existence of such an interaction since our system
allowed us to completely delete RRE, something thatRev was provided instead of SIV Rev, leading to suboptimal
rescue of virus replication. Regardless of the lower effi- could not be achieved in earlier reports showing Rev/
RRE-independent replication of HIV-1 (3, 32). In the caseciency of rescue by Rev, these results indicate that the
trans complementation system could be used to study the of SIV, viral titers obtained with the Rev(/)RRE(0)CTE(/)
vector, pTR229 (197 CFU/ml; Table 1), were the sameeffects of MPMV CTE in replacing Rev/RRE functions in a
single round of replication. as titers obtained with the Rev(0)RRE(0)CTE(/) vector,
pTR247 (199 CFU/ml; Table 1). If a positive interactionWhen the MPMV CTE was inserted in the nef region
of Rev(/)RRE(0) vector pTR229, the MPMV CTE was between Rev and CTE existed, we should have observed
higher titers with pTR229 [Rev(/)RRE(0)CTE(/)]. As aable to compensate for the defect in the Rev/RRE regula-
tory system and rescue vector propagation (Table 1). corollary, our results further show that Rev functions only
in conjunction with RRE and does not seem to have anyHowever, vector propagation was 16-fold less efficient
compared with that of pTR140 (197 vs 3168 CFU/ml). As other roles in the viral life cycle except regulation of the
expression of viral messages.expected, the MPMV CTE was unable to compensate
for the Rev/RRE system when inserted in the opposite Next we examined whether MPMV CTE could substi-
tute for Rev and RRE functions in a region different fromorientation, as seen for pTR230 (Table 1); this result
agreed with those of Bray et al. (3). Similar to pTR229, nef where its insertion did not disrupt any known ORFs
critical for SIV replication and pathogenesis in vivo. Thewhen MPMV CTE was inserted in the Rev(0)RRE(/) vec-
tor, pTR245, MPMV CTE was able to rescue infection, MPMV CTE was inserted at the junction of vpx and vpr
using splice overlap extension (SOE) PCR (Fig. 2) (15).though again at a 16-fold lower efficiency compared to
that of pTR140 (193 vs 3168 CFU/ml). When HIV-1 Rev vpx and vpr do not have any area of overlap; therefore,
insertion of the CTE between the stop codon for vpx andwas provided in trans with pTR245, virus could be res-
cued to approximately the same level as with pTR238 the initiation codon for vpr did not disrupt vpx, vpr, or
any other known ORFs. This was accomplished for the(869 vs 1050 CFU/ml; Table 1). When the MPMV CTE
was inserted in the nef region of the Rev(0)RRE(0) dou- Rev(/)RRE(/) vector, pTR304, the Rev(/)RRE(0) vector,
pTR255, and the double mutant Rev(0) RRE(0) vector,ble mutant, pTR247, virus replication was observed at a
rate similar to that of pTR229 or pTR245 (199 vs 197 or pTR258. Testing of these molecular clones in the trans
complementation assay revealed that the control vector,193 CFU/ml). These data strongly suggest that MPMV
CTE can substitute for the function of the SIV Rev/RRE pTR304, could replicate as well as the wild-type CTE(0)
vector, pTR140, suggesting that insertion of CTE at theregulatory system though at a 16-fold lower efficiency.
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is critical in its ability to substitute for the Rev/RRE regula-
tory system in the replication of SIV. Retention of the
introduced CTE in the Nef ORF and at the junction of vpx
and vpr and no reversion of Rev mutations were con-
firmed by PCR and subsequent sequence analyses (data
not shown).
Since our trans complementation assay required the
expression of gag/pol for particle formation, we next at-
tempted to test whether the MPMV CTE could substitute
for the function of Rev/RRE regulatory system in the con-
text of a heterologous promoter. SIV gag/pol sequences
were cloned into an expression plasmid containing the
human cytomegalovirus (CMV) promoter and the bovine
growth hormone polyadenylation sequences either with
MPMV CTE (pRS102) or without (pRS106) (Fig. 3A). Co-
transfection of these plasmids into Cos cells along with
a control DNA expressing human growth hormone (hGH)
revealed that SIV gag/pol expression was dependent
upon the presence of CTE. In the absence of CTE, only
1.91 ng/ml of p27 antigen was released in the Cos super-
natants compared to 30.5 ng/ml released in the presence
FIG. 2. Schematic representation of the SIVmac239 genome with
open reading frames (ORFs) and SIV vectors with the insertion of MPMV
CTE at the junction of vpx and vpr using splice overlap extension PCR.
Four rounds of PCR were performed to insert MPMV CTE between the
stop codon of SIV vpx (TAA) and the start codon of vpr (ATG) without
disrupting either ORF. Details of the PCR amplification and construction
of these plasmids can be obtained from the authors upon request. The
MPMV CTE is shown as a black box. Annealing sites of PCR amplifica-
tion primers used are shown with respect to the stop codon of vpx and
start codon of vpr. Portions of hybrid primers that do not anneal are
shown with offset portions. The broken lines represent the site of in
vitro ligation of the SIV vectors with p239SpSp5* at the BstBI site. RRE,
Rev-responsive element; SV, SV40 early promoter; hyg r, hygromycin B
phosphotransferase gene.
junction of vpx and vpr did not have any adverse effects FIG. 3. Comparison of SIV gag/pol expression in the presence or
absence of MPMV CTE. (A) SIVmac239 gag/pol expression constructs.on the replication of SIV (Table 1). However, insertion of
Details of the origin and construction of these plasmids can be obtainedMPMV CTE could rescue replication of Rev(/)RRE(0)
from the authors upon request. CMV, human cytomegalovirus promoter;vector pTR255 by only 1/140 (or 0.007) of the wild-type
BGH, bovine growth hormone; poly A, polyadenylation sequences. (B)
level and that of the Rev(0)RRE(0) double mutant, Quantitative measurement of the p27 Gag antigen released in the me-
pTR258, by 1/200 (or 0.005) of the wild-type level (Table dia 72 hr after transfection using the Coulter p27 Antigen Capture
Assay. pJW4303, control plasmid.1). These results suggest that the location of MPMV CTE
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TABLE 2
Effect of MPMV CTE on the Propagation of Rev(0), RRE(0), and Rev(0)RRE(0) HIV-1 Vectorsa,b
Titer (CFU/ml { SD)c
HIV-1 Rev
Rev/RRE Presence or absence of
Vector phenotype MPMV CTE in the nef region (/) (0)
pGB108 Rev(/)RRE(/) CTE(0) NDd 5864 { 118
pTR211 Rev(/)RRE(0) CTE(0) ND 0
pTR226 Rev(/)RRE(0) CTE(/) ND 364 { 5
pTR237 Rev(0)RRE(/) CTE(0) 1580 { 20 0
pTR233 Rev(0)RRE(/) CTE(/) 1570 { 26 355 { 4
pTR236 Rev(0)RRE(0) CTE(0) ND 0
pTR241 Rev(0)RRE(0) CTE(/) ND 346 { 5
a pGB108 was modified to create Rev(0), RRE(0), and Rev(0)RRE(0) vectors, the details of which can be obtained from the authors upon request.
b All vectors were cotransfected with pSV-A-MLV-env.
c All data represent experiments performed in parallel and are based on a minimum of three independent experiments with two duplicate samples
per experiment. No Hygr colonies were observed for mock, pSV-A-MLV-env alone, or any of the vectors when transfected without pSV-A-MLV-env.
d ND, Not done.
of CTE (Fig. 3B). Similarly, we have successfully ex- XhoI site in the nef gene, similar results were obtained
as seen for the SIV vectors. Insertion of the CTE in thepressed SIV gag only from a heterologous promoter in
the presence of MPMV CTE (data not shown). These Rev(/)RRE(0) vector, pTR226, rescued viral replication
from 0 to 364 CFU/ml (Table 2). This is 16-fold lowerresults are in agreement with observations in the HIV-1
system in which the expression of HIV-1 Gag/Pol mes- than the replication observed with pGB108, the wild-type
vector (5864 CFU/ml). Similarly, when CTE was insertedsage was shown to be dependent upon the presence of
CTE in the absence of Rev/RRE (3). in the Rev(0)RRE(/) vector, pTR233, viral titers of 355
CFU/ml were obtained, which again is 16-fold lower thanSince the earlier published reports on Rev/RRE-inde-
pendent replication of HIV-1 using CTE used multiple the wild-type titer. Complementing pTR233 with Rev in
trans increased viral titers to the same level as forrounds of replication assays resulting in discrepancies
in the extent of the ability of CTE to rescue replication pTR237 (1570 vs 1580 CFU/ml), consistent with results
obtained with the SIV vectors. Finally, when the doubleof HIV-1, we wished to reevaluate those studies using a
single round of replication assay. Toward this end, a mutant, pTR241, was complemented in cis by MPMV CTE
insertion in the nef gene, the MPMV CTE was able toset of env-defective HIV-1 clones containing the SV-Hygr
cassette was constructed analogous to SIVmac239 de- rescue vector propagation, but again the titers were 16-
fold lower than the wild-type titers (346 vs 5864 CFU/ml).fective for Rev, RRE, or both Rev and RRE with or without
insertions of MPMV CTE. Table 2 reveals the results of These results reveal very consistently that MPMV CTE
can substitute for the Rev/RRE regulatory system for bothseveral trans complementation experiments performed
using these HIV-1 vectors with or without the MPMV SIV and HIV-1 with a 16-fold lower efficiency. These re-
sults also reveal that the extent of attenuation observedCTE. The control vector pGB108 (described in 12), which
contains all intact HIV-1 genes except env, was able to with substitution of the Rev/RRE system by CTE in HIV-
1 is closer to results published by Zolotukhin et al. (32)replicate well, giving rise to 5864 CFU/ml of virus stock.
As expected, when RRE was deleted in pGB108, creating than those of Bray et al. (3). Zolotukhin et al. (32), using
SRV-1 CTE, observed a 5- to 10-fold lower efficiency ofpTR211, or when Rev was mutated, as in pTR237, or
when both Rev and RRE were disrupted, as in pTR236, no replication than did Bray et al. (3), who found a two orders
of magnitude difference in the ability of MPMV CTE-con-colonies were observed (Table 2). Similar to the results
obtained for the SIV vectors, when the RRE(/) vector, taining molecular clones to replicate.
It is not clear exactly what the mechanism of CTEpTR237, was complemented with Rev in trans, viral repli-
cation was restored, though it was three- to fourfold lower action is. It may serve to facilitate the export of unspliced
or partially spliced mRNAs from the nucleus to the cyto-than the wild-type levels (1580 vs 5864 CFU/ml). The
higher titers observed for the HIV-1 vectors compared to plasm, as suggested by Bray et al. (3). However, MPMV
does not contain any accessory genes analogous to RevSIV are probably due to the need for in vitro ligation of
the two halves of SIV vectors to generate infectious virus, to carry out such a function. Thus, CTE may act as a
nuclear export signal in the life cycle of MPMV by usingwhereas no such need exists for HIV-1.
When the Rev- and RRE-defective viruses were com- cellular factors rather than viral trans-acting factors to
promote expression of unspliced and partially splicedplemented with MPMV CTE in cis by its insertion at the
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